Applying Hydrophobically Conjugated siRNAs to the Treatment of Muscular Diseases
Time: 11:30 am
day: Conference Day One
Details:
- A combinatorial treatment strategy for reducing heterotopic bone in a mouse model of Fibrodysplasia Ossificans Progressiva (FOP)
- Identification of a SNP-targeting siRNA against the mutant ACVR1 receptor implicated in FOP
- Systemic delivery of hydrophobic siRNAs to the muscle
UNPUBLISHED DATA
